New MRI technique aims to spare healthy lung during cancer radiation

NCT ID NCT07355231

Not yet recruiting Disease control Sponsor: Xemed LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tests whether a special MRI scan using hyperpolarized xenon gas can help doctors plan radiation treatment for non-small cell lung cancer. The goal is to deliver enough radiation to the tumor while avoiding healthy lung tissue, which could reduce side effects like breathing problems. Ten patients will be scanned before and after radiation, and their lung function and quality of life will be tracked for six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hyperpolarized xenon MRI
What this could lead to: If successful, this imaging method could help doctors plan radiation to better protect healthy lung tissue, potentially reducing breathing problems after treatment.
What could go wrong: This is a very small early-phase trial with only 10 participants, so results may not apply to everyone. The imaging technique is still experimental and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA, NON-SMALL-CELL LUNG

More trials for these conditions

Other studies related to the condition(s) this trial covers.